Aventis

Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24
Fierce Biotech
Wed, 04/3/24 - 11:36 am
biotech
M&A
IPOs
CG Oncology
Kyverna Therapeutics
Contineum Therapeutics
Boundless Bio
CymaBay Therapeutics
Gilead Sciences
MorphoSys
Novartis
Fusion Pharmaceuticals
AstraZeneca
Ambryx
JNJ
Inhibrix
Aventis
Aventis to Pay $828,500 in Drug Pricing Settlement
Equities.com
Sat, 08/4/12 - 12:54 pm
Aventis
legal
Biggest Battles in Biopharma
Fierce Pharma
Wed, 09/8/10 - 11:33 am
Sun Pharma
Taro
Pfizer
Warner-Lambert
Aventis
Sanofi-Synthelabo
Astellas
OSI Pharmaceuticals
King
Alpharma
Novartis
Carl Icahn
Bristol-Myers Squibb
Alcon
Genzyme
Cheaper Eye Drug May Threaten Novartis and Roche Sales
CNBC
Mon, 02/1/10 - 08:27 pm
Novartis
Roche
Lucentis
Aventis
Biotech drug approvals spiked in 2009
Fierce Biotech
Wed, 01/6/10 - 08:45 am
biotech
Eli Lilly
Effient
Daiichi Sankyo
denosumab
Amgen
Aventis
Multaq
Colorado gets $376K in Aventis settlement
Bizjournals.com
Tue, 06/9/09 - 03:08 pm
Aventis
Colorado
settlements